Delivery Order SPE2DB22D1017-SPE2DB24FF2NU
Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $3.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of a pharmaceutical product - VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. This contract has a potential value of $7,125.13 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not a set-aside contract. The company also holds an indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract, which has a potential value of $2,838.72, has a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the sole prime contractor on this award, which is not set aside for any small business or disadvantaged business designations. In...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceuticals. The contract has a potential value of $10,598.71 and a completion date of January 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The order has a potential value of $1,891.09 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product VICTOZA 2-PAK 18 MG/3 ML PEN 3ML. The contract has a potential value of $7,528.10 and a completion date of February 20, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,128.68 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML medication, with a completion date of February 1, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contract awards from DLA Troop Support Medical to provide pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $8,550.85 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. This order was placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, is a major...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,419.36 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. This award is part of a broader indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00, to deliver a wide range of pharmaceuticals and medical supplies in support of the Department of Defense's military...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. The contract has a ceiling value of $1,921.41 and is a Firm Fixed Price delivery order with a completion date of September 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) until June 2025....
- This federal contract award, valued at $15,737.53, was granted to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA) for the delivery of VICTOZA 3-PAK 18 MG/3 ML PEN 3ML pharmaceutical products. The contract has an ultimate completion date of August 27, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF2NUDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563589162 VICTOZA 3-PAK 18 MG/3 ML PEN 3ML. The contract has a potential value of $3,687.60 and a completion date of February 8, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. No set-aside designation was used for this contract award.
Generated 5/8/24, 11:04 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 2/7/24 |